IPS

 Versa Networks Awarded Common Criteria Certificate and Product Compliant Listing by NIAP for its Next Generation Security Capabilities

Retrieved on: 
Tuesday, April 16, 2024
Technology, Other Defense, Contracts, Security, Software, Networks, Government Technology, Artificial Intelligence, Defense, Versa, NIAP, FFW, IPS, Government, Executive order, Certification, Common Criteria, PCL, Security agency, Intrusion detection system, VOS, Information technology, Federation, NSA, NIST, Network, National Information Assurance Partnership, CNSA

Versa Networks, the global leader in AI/ML-powered Unified Secure Access Service Edge (SASE) and Software Defined WAN (SD-WAN), today announced that it has been awarded a National Information Assurance Partnership (NIAP) Common Criteria certificate.

Key Points: 
  • Versa Networks, the global leader in AI/ML-powered Unified Secure Access Service Edge (SASE) and Software Defined WAN (SD-WAN), today announced that it has been awarded a National Information Assurance Partnership (NIAP) Common Criteria certificate.
  • NIAP is a United States Government initiative operated by the National Security Agency (NSA) to meet the security testing needs of both information technology consumers and producers.
  • NIAP maintains the U.S. Government’s Product Compliant List (PCL), providing a list of commercial products approved for procurement for use within National Security Systems and across the entire federal government.
  • NIAP is also part of the global Common Criteria Recognition Arrangement, providing reciprocity for product acceptance among the broader set of countries that participate in the Common Criteria.

Intertrust Partners with GeoComply for Advanced Geolocation-Enabled Content Protection

Retrieved on: 
Friday, April 12, 2024
Mobile, Wireless, Technology, Security, Telecommunications, Software, Audio, Video, Networks, Internet, Data Management, IOT (Internet of Things), Media, Product marketing, IPS, Partnership, Intertrust, Virtual private network, DRM, Music

Intertrust, the global leader in distributed computing and rights management, and GeoComply Solutions Inc. (“GeoComply”), a renowned provider of geolocation compliance technology and fraud protection, today announced a partnership to provide a robust solution for content owners and streaming services to control where and how their digital content is delivered and consumed.

Key Points: 
  • Intertrust, the global leader in distributed computing and rights management, and GeoComply Solutions Inc. (“GeoComply”), a renowned provider of geolocation compliance technology and fraud protection, today announced a partnership to provide a robust solution for content owners and streaming services to control where and how their digital content is delivered and consumed.
  • The partnership will enhance digital content security, reduce revenue loss from piracy, and ensure compliance with licensing agreements that often include geographic restrictions.
  • The integration of Intertrust ExpressPlay with GeoComply adds an additional layer of protection and services that enable the secure distribution of content and ensure authorized access.
  • “Our partnership with Intertrust further cements our mission to redefine content protection and location security for the Media & Entertainment industry,” stated James Clark, GM Media & Entertainment at GeoComply.

M31 has successfully launched MIPI C/D PHY Combo IP on the advanced TSMC 5nm process

Retrieved on: 
Thursday, April 25, 2024
Internet of things, TSMC, IP, AI, PCI Express, Silicon, IPS, OIP, R&D, PHY, Standard cell, ADAS, Artificial intelligence, ALP, MIPI, GPIO, Intellectual property, Multimedia, M31, Partner, Socs

HSINCHU, April 25, 2024 /PRNewswire/ -- M31 Technology Corporation (M31), a leading global provider of silicon intellectual property (IP), announced that the M31 MIPI C/D-PHY Combo IP has obtained silicon validation on the advanced TSMC 5nm process and the company has already started 3nm IP development.

Key Points: 
  • HSINCHU, April 25, 2024 /PRNewswire/ -- M31 Technology Corporation (M31), a leading global provider of silicon intellectual property (IP), announced that the M31 MIPI C/D-PHY Combo IP has obtained silicon validation on the advanced TSMC 5nm process and the company has already started 3nm IP development.
  • M31 has been honored with the TSMC Open Innovation Platform® (OIP) Partner of the Year Award for Special Process IP for six consecutive years.
  • M31 also introduced the 5nm MIPI C/D PHY Combo IP that complies with the latest D-PHY v2.5 and C-PHY v2.0 specifications.
  • Looking ahead, M31 will closely follow TSMC's advanced process technology, continue to invest in R&D resources, develop products using advanced process technology, and expand IP solutions in emerging application areas such as AI, IoT, and 5G communication, to help customers accelerate product launches and enhance market competitiveness."

iQIYI Launches Over 300 Titles at 2024 World Conference, Fueling Growth with Diverse Content and Robust IP Monetization

Retrieved on: 
Thursday, April 25, 2024
IP, Collegiate summer baseball, Rapping, Wonder, UEFA, AI, Series, IPS, Partnership, Conference, Literature, Fearless, VR, Theatre, Golf, Tennis, Season, Multimedia, Detective, Creativity, UEFA European Championship, IQIYI, The Rap of China, Growth, Father, Industrial design

BEIJING, April 25, 2024 /PRNewswire/ -- iQIYI, an innovative market-leading online entertainment service in China, announced an exciting lineup of over 300 new titles across genres at the iQIYI 2024 World Conference held on April 23-24. The company also introduced two new drama series brands and forged multiple strategic partnerships aimed at fueling growth with its premium content offerings and IP development.

Key Points: 
  • The company also introduced two new drama series brands and forged multiple strategic partnerships aimed at fueling growth with its premium content offerings and IP development.
  • Yu GONG, Founder and CEO of iQIYI, highlighted the company's commitment to realism in content creation and delivering high-quality and diverse offerings.
  • Xiaohui WANG, Chief Content Officer at iQIYI, emphasized the company's steadfast commitment to fostering creative diversity and innovation among its studios.
  • Liu believes that AI-generated content should not be misinterpreted as competing with professionally produced content and user-generated content.

Bigglz: Bring the character to life

Retrieved on: 
Wednesday, April 24, 2024
Hallucination, Immersion, IP, Mandalay Bay Convention Center, ChatGPT, GTP, AI, IPS, LLM, RAG, Tamagotchi, Brain, Database, Multimedia, MAU, Virtual character

LAS VEGAS, April 24, 2024 /PRNewswire/ -- Korean company Bigglz( www.bigglz.com ) will show its character IP and attractive AI technologies at Las Vegas Licensing Expo 2024.

Key Points: 
  • LAS VEGAS, April 24, 2024 /PRNewswire/ -- Korean company Bigglz( www.bigglz.com ) will show its character IP and attractive AI technologies at Las Vegas Licensing Expo 2024.
  • However, Bigglz solved this problem with special RAG technology and AI technologies such as prompt engineering.
  • The key to a conversation with a virtual character is to form a natural bond of sympathy.
  • Troy Malone, CEO of Relevant, a global partner, said, "The Bigglz's AI chatbot will definitely provide fans with an innovative fan experience.

RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study

Retrieved on: 
Wednesday, April 24, 2024
Acute radiation syndrome, Bangladesh Technical Education Board, PROTECT, Safety, SARS-CoV-2, Austerity, IPS, Military medicine, Consortium, United States Army, Patient, HJF, Hospital, COVID-19, Pharmaceutical industry

RALEIGH, N.C. and TEL-AVIV, Israel, April 24, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the first patient has been enrolled in the Austere environments Consortium for Enhanced Sepsis Outcomes' (ACESO) U.S. government-supported PROTECT multinational platform trial for early COVID-19 outpatient treatment. RHB-107 (upamostat) is the first drug being tested in this platform study. Funded through non-dilutive external sources, including the U.S. Department of Defense, the PROTECT study is expected to be conducted in the U.S., Thailand, Ivory Coast, South Africa and Uganda, and is estimated to be completed by the end of 2024.

Key Points: 
  • RHB-107 (upamostat) is the first drug being tested in this platform study.
  • Phase 2 study," said Gilead Raday, RedHill's Chief Operating Officer and Head of R&D.
  • "RHB-107 is a novel, potentially broad-acting, host-directed antiviral that is expected to act independently of viral spike protein mutations.
  • RHB-107 is the initial drug being evaluated in the early treatment arm of the study.

GuildFi, Now Zentry, to Build a Superlayer Uniting the World's Three Billion Gamers in One Vibrant Play Economy

Retrieved on: 
Tuesday, April 23, 2024
Blog, Shrapnel, Ecosystem, IP, Investment, Social media, IPS, Blockchain, Love, Discord, Web 2.0, DAO, GF, Pantera Capital, IRL, Coffee

BANGKOK, April 23, 2024 /PRNewswire/ -- GuildFi, a leading web3 gaming guild that raised $140 million from Binance Labs, Coinbase Ventures, Animoca, Pantera Capital, Hashed and others, has strategically rebranded to Zentry. Designed to bring the MMORPG experience into real life, Zentry is building a universal Superlayer that will connect all games, regardless of platform, into a unified Play Economy.

Key Points: 
  • Designed to bring the MMORPG experience into real life, Zentry is building a universal Superlayer that will connect all games, regardless of platform, into a unified Play Economy.
  • Zentry's Superlayer seamlessly blends loyalty systems, gamer identities, and cross-world activities from countless games and platforms into a single overlay experience.
  • "In this new Play Economy, you can buy a coffee from your barista and your Zentry character gets a perk, or vice versa."
  • Read Zentry's blog for more information, and stay up to date by joining Zentry's Discord and following on X @ ZentryHQ .

Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting

Retrieved on: 
Tuesday, April 23, 2024
Ballroom, Safety, Transgene, Express, Lipid, Monocyte, Chromatin, Research fellow, IPS, MD, Cell, Gene targeting, Development, Macrophage, DNA, Gene, Society, Messenger, Annual general meeting, Dicarboxylic acid, Vaccine

CAMBRIDGE, Mass., April 23, 2024 /PRNewswire/ -- Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting to be held in Baltimore, MD from May 7-11, 2024. Factor will deliver seven presentations, representing the company's most expansive presentation of data to date.

Key Points: 
  • CAMBRIDGE, Mass., April 23, 2024 /PRNewswire/ -- Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting to be held in Baltimore, MD from May 7-11, 2024.
  • Factor will deliver seven presentations, representing the company's most expansive presentation of data to date.
  • "Factor will deliver seven presentations, representing the company's most expansive presentation of data to date."
  • For more information about the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, visit annualmeeting.asgct.org .

Panasonic and Shinobi Therapeutics Partner to Develop Efficient and Cost-Effective iPS Cell Therapy Manufacturing Technology

Retrieved on: 
Thursday, April 18, 2024
Organization, Safety, IPS, Partnership, Panasonic, Cell, Research, Entrepreneurship, Engineering, Nobel, Patient, IPSC, Bone marrow, CIRA, Health, Therapy, Biotechnology, SAN, Escape Room, Pharmaceutical industry

SAN FRANCISCO and KYOTO, Japan, April 18, 2024 /PRNewswire/ -- Shinobi Therapeutics, a biotechnology company developing a new class of immune evasive iPS cell therapies, today announced a partnership with Panasonic Holdings Corp and Kyoto University's Center for iPS Cell Research and Application (CiRA).

Key Points: 
  • SAN FRANCISCO and KYOTO, Japan, April 18, 2024 /PRNewswire/ -- Shinobi Therapeutics, a biotechnology company developing a new class of immune evasive iPS cell therapies, today announced a partnership with Panasonic Holdings Corp and Kyoto University's Center for iPS Cell Research and Application (CiRA).
  • Through this strategic collaboration, the organizations aim to engineer a novel manufacturing platform to produce iPS-T cell therapies more efficiently and at lower cost than is possible with currently available technology.
  • "Advancements in iPS cell production and Shinobi's genetic modification of iPSCs for immune evasion have made regenerative T cell therapy increasingly feasible," said Shin Kaneko, Co-Founder at Shinobi.
  • The newly announced partnership will leverage Panasonic's manufacturing expertise to develop a new method of producing iPS-T cell therapies in a closed-system process.

Acer Expands Chromebook Plus Laptop Lineup with New 14-Inch Model Powered by Intel Core Processors

Retrieved on: 
Thursday, April 18, 2024
USD, Full, Acer, Connectivity, System, Adobe Photoshop, Google Photos, IPS, AI, RAM, Compact, School, ChromeOS, Notebook, Sync, Adobe, Wi-Fi 6, Acer Inc., EUR, Student, Environment, Energy Star, HD, Lighting, Privacy, Chromebook, LPDDR5, Memory, Creativity, Running, Google Docs, USB, Cobalt, EPEAT, TNR

TAIPEI, April 18, 2024 /PRNewswire/ -- Acer today expanded its line of Chromebook Plus laptops with the Acer Chromebook Plus 514 (CB514-4H/T), providing users with a performance-minded, compact and durable model that enables them to do more with the AI-powered capabilities of ChromeOS.

Key Points: 
  • The new Acer Chromebook Plus 514 is the latest addition to Acer's lineup of Chromebook Plus laptops that offer enhanced Chromebook performance and experiences, emphasizing better hardware designs with upgraded displays and cameras paired with powerful productivity, creativity, and multimedia capabilities.
  • Like all Acer Chromebook Plus laptops , users have the power to do more with the new Chromebook Plus 514 (CB514-4H/T).
  • When Acer Chromebook Plus 514 users are away from an internet connection, File sync on Chromebook Plus keeps Google Docs, Sheets, and Slides always accessible, whether online or offline[6].
  • The new Acer Chromebook Plus 514 is available with Chrome Education Upgrade for seamless device management in schools.